.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Harvard Business School
Chubb
Deloitte
Cerilliant
Farmers Insurance
Cipla
Julphar
Novartis

Generated: June 23, 2017

DrugPatentWatch Database Preview

CISPLATIN Drug Profile

« Back to Dashboard

Which patents cover Cisplatin, and what generic Cisplatin alternatives are available?

Cisplatin is a drug marketed by Bedford, Teva Pharms Usa, Gland Pharma Ltd, Fresenius Kabi Usa, West-ward Pharms Int, Pharmachemie Bv, Hq Spclt Pharma, Mylan Labs Ltd, and Accord Hlthcare. and is included in nine NDAs.

The generic ingredient in CISPLATIN is cisplatin. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cisplatin profile page.

Summary for Tradename: CISPLATIN

Patents:0
Applicants:9
NDAs:9
Suppliers / Packagers: see list9
Clinical Trials: see list2,521
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CISPLATIN at DailyMed

Pharmacology for Tradename: CISPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford
CISPLATIN
cisplatin
INJECTABLE;INJECTION074713-001Nov 14, 2000DISCNNoNo► Subscribe► Subscribe
Pharmachemie Bv
CISPLATIN
cisplatin
INJECTABLE;INJECTION074656-001May 16, 2000APRXNoNo► Subscribe► Subscribe
Gland Pharma Ltd
CISPLATIN
cisplatin
INJECTABLE;INJECTION207323-001Mar 17, 2017APRXNoNo► Subscribe► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 1988APRXYesNo► Subscribe► Subscribe
Bedford
CISPLATIN
cisplatin
INJECTABLE;INJECTION074713-002Nov 14, 2000DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CISPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 19884,177,263► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 19885,562,925► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 19884,310,515► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Harvard Business School
McKinsey
Chinese Patent Office
Fuji
Deloitte
Healthtrust
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot